Life Science (UK) Today
| LABS Stock | 34.90 0.40 1.13% |
Performance0 of 100
| Odds Of DistressOver 64
|
Life Science is selling for under 34.90 as of the 10th of January 2025; that is 1.13 percent decrease since the beginning of the trading day. The stock's lowest day price was 34.5. Life Science has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of January 2023 and ending today, the 10th of January 2025. Click here to learn more.
Business Domain Equity Real Estate Investment Trusts (REITs) | Category Real Estate |
Life Science is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 350 M outstanding shares. More on Life Science REIT
Moving together with Life Stock
Moving against Life Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Life Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Life Science's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Life Science or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diversified REITs, Equity Real Estate Investment Trusts (REITs), Real Estate, Real Estate, Diversified REITs, Equity Real Estate Investment Trusts (REITs), Real Estate (View all Sectors) | ||||
Life Science's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Life Science's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsLife Science can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Life Science's financial leverage. It provides some insight into what part of Life Science's total assets is financed by creditors.
| |||||
Life Science REIT (LABS) is traded on London Exchange in UK and employs 9 people. Life Science is listed under Diversified REITs category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 128.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Life Science's market, we take the total number of its shares issued and multiply it by Life Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Life Science REIT operates under Diversified REITs sector and is part of Real Estate industry. The entity has 350 M outstanding shares.
Life Science generates positive cash flow from operations, but has no cash available
Check Life Science Probability Of Bankruptcy
Ownership AllocationLife Science REIT maintains a total of 350 Million outstanding shares. The majority of Life Science outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Life Science REIT to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Life Science REIT. Please pay attention to any change in the institutional holdings of Life Science as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Life Ownership Details
Life Science REIT Risk Profiles
Although Life Science's alpha and beta are two of the key measurements used to evaluate Life Science's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.17 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.66 | |||
| Risk Adjusted Performance | (0.08) |
Life Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Life Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Life Science Corporate Directors
| Sally OBE | Independent Director | Profile | |
| Ian Harris | Director Management | Profile | |
| David Lewis | Director Limited | Profile | |
| Simon Farnsworth | Managing Director | Profile |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.